Equity Capital: 63.79 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 21,593.44 | 39,409.91 |
LAST 3M | 57,905.00 | 19,139.45 |
LAST 6M | 99,888.55 | 93,017.93 |
LAST 12M | 166,353.23 | 137,771.51 |
Date | Action Type | Ratio |
---|---|---|
Sep 18, 2023 | Dividend | 10 |
Sep 13, 2022 | Dividend | 10 |
Sep 16, 2021 | Dividend | 10 |
Bal Pharma (BPL), a member of the Mcro Laboratories group, was incorporated as a private limited company in May `87. In Mar.`90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.`95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company`s product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named "SERVETUS" has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002.
21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092
: | secretarial:balpharma.com/info:balpharma.com | |
Website | : | http://www.balpharma.com |
TSR Consultants P Ltd
AGM Date (Month) | : | Sep |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 524824 |
NSE Code | : | BALPHARMA |
Book Closure Date (Month) | : | Sep |
BSE Group | : | B |
ISIN | : | INE083D01012 |
You can buy Bal Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bal Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Dec 08, 2023 02:14 PM the closing price of Bal Pharma Ltd was ₹ 105.75.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 08, 2023 02:14 PM, the market cap of Bal Pharma Ltd stood at ₹ 165.92.
The latest PE ratio of Bal Pharma Ltd as of Dec 08, 2023 02:14 PM is 52.49
The latest PB ratio of Bal Pharma Ltd as of Dec 08, 2023 02:14 PM is 0.38
The 52-week high of Bal Pharma Ltd is ₹ 118.35 while the 52-week low is ₹ 63.35